JP2023527396A5 - - Google Patents
Info
- Publication number
- JP2023527396A5 JP2023527396A5 JP2022572736A JP2022572736A JP2023527396A5 JP 2023527396 A5 JP2023527396 A5 JP 2023527396A5 JP 2022572736 A JP2022572736 A JP 2022572736A JP 2022572736 A JP2022572736 A JP 2022572736A JP 2023527396 A5 JP2023527396 A5 JP 2023527396A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- symptoms
- alkyl
- pharmaceutically acceptable
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063030968P | 2020-05-28 | 2020-05-28 | |
| US63/030,968 | 2020-05-28 | ||
| PCT/US2021/034454 WO2021242982A1 (en) | 2020-05-28 | 2021-05-27 | Galectin-3 inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023527396A JP2023527396A (ja) | 2023-06-28 |
| JP2023527396A5 true JP2023527396A5 (https=) | 2024-06-03 |
| JP7772718B2 JP7772718B2 (ja) | 2025-11-18 |
Family
ID=76502884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022572736A Active JP7772718B2 (ja) | 2020-05-28 | 2021-05-27 | ガレクチン－３阻害剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12291522B2 (https=) |
| EP (1) | EP4157833A1 (https=) |
| JP (1) | JP7772718B2 (https=) |
| KR (1) | KR20230018431A (https=) |
| CN (1) | CN115768768A (https=) |
| WO (1) | WO2021242982A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026002250A1 (zh) * | 2024-06-28 | 2026-01-02 | 上海济煜医药科技股份有限公司 | 四唑基取代的吡喃半乳糖苷衍生物及其制备方法和应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0401301D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel 3-triazolyl-galactoside inhibitors of galectins |
| SE0401300D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel Galactoside Inhibitors of Galectins |
| DK2906227T3 (en) | 2012-10-10 | 2018-12-10 | Galectin Therapeutics Inc | GALACTOSE-CONTAINING CARBOHYDRATE COMPOUNDS FOR THE TREATMENT OF DIABETIC Nephropathy |
| CN104755088A (zh) | 2012-10-31 | 2015-07-01 | 格莱克特生物技术公司 | 半乳凝集素-3的半乳糖苷抑制剂及其用于治疗肺纤维化的应用 |
| CA2970062C (en) | 2015-01-30 | 2023-02-28 | Galecto Biotech Ab | Alpha-d-galactoside inhibitors of galectins |
| CA3000924A1 (en) | 2015-11-09 | 2017-05-18 | Galecto Biotech Ab | Novel galactoside inhibitors of galectins |
| JP2020505327A (ja) | 2016-12-23 | 2020-02-20 | アルビナス・オペレーションズ・インコーポレイテッドＡｒｖｉｎａｓ Ｏｐｅｒａｔｉｏｎｓ， Ｉｎｃ． | Ｅｇｆｒタンパク質分解標的化キメラ分子およびその関連する使用方法 |
| EP3621973A4 (en) | 2017-05-12 | 2021-10-27 | Galectin Sciences, LLC | COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DISEASES AND USES THEREOF |
| ES2965049T3 (es) | 2017-07-12 | 2024-04-10 | Dana Farber Cancer Inst Inc | Compuestos para la degradación de la proteína tau |
| WO2019067702A1 (en) | 2017-09-27 | 2019-04-04 | Bristol-Myers Squibb Company | INHIBITORS WITH SMALL MOLECULES OF GALECTIN-3 |
| US11072626B2 (en) | 2017-10-11 | 2021-07-27 | Bristol-Myers Squibb Company | Small molecule inhibitors of Galectin-3 |
| JP2021515013A (ja) | 2018-03-06 | 2021-06-17 | アイカーン スクール オブ メディスン アット マウント シナイ | セリンスレオニンキナーゼ（ａｋｔ）分解／破壊化合物および使用方法 |
| CN112292386B (zh) | 2018-06-15 | 2024-06-11 | 百时美施贵宝公司 | 作为半乳凝素-3抑制剂的基于四氢吡喃的硫代二糖模拟物 |
| JP7472103B2 (ja) | 2018-08-22 | 2024-04-22 | クルゲン（シャンハイ），インク． | トロポミオシン受容体キナーゼ（ｔｒｋ）分解化合物とその使用方法 |
-
2021
- 2021-05-27 KR KR1020227045460A patent/KR20230018431A/ko active Pending
- 2021-05-27 EP EP21733338.4A patent/EP4157833A1/en active Pending
- 2021-05-27 CN CN202180038169.4A patent/CN115768768A/zh active Pending
- 2021-05-27 US US17/927,426 patent/US12291522B2/en active Active
- 2021-05-27 WO PCT/US2021/034454 patent/WO2021242982A1/en not_active Ceased
- 2021-05-27 JP JP2022572736A patent/JP7772718B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022527395A5 (https=) | ||
| JP2022527075A5 (https=) | ||
| JP2025512474A5 (https=) | ||
| JP2021527102A5 (https=) | ||
| JP2016517432A5 (https=) | ||
| JP2020510664A5 (https=) | ||
| JP7656669B2 (ja) | マトリックスメタロプロテイナーゼ（ｍｍｐ）阻害剤及びその使用方法 | |
| KR102890853B1 (ko) | 갈렉틴-3의 소분자 억제제 | |
| JP2005504789A5 (https=) | ||
| JP2019504899A5 (https=) | ||
| JP2019504898A5 (https=) | ||
| JP2013526494A5 (https=) | ||
| BRPI0712268A2 (pt) | composição para diagnóstico de doença relacionada à amilóide | |
| JP2009512640A (ja) | 新規化合物 | |
| JP2023527396A5 (https=) | ||
| RU2012144332A (ru) | Циклоалкил-замещенное производное имидазола | |
| JP2021523241A5 (https=) | ||
| JP2021528451A5 (https=) | ||
| WO2007002637B1 (en) | N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions | |
| JP2021534254A5 (ja) | 心臓弁疾患を治療するための医薬組成物 | |
| JP2008517954A (ja) | 抗血小板剤としての置換ピリドキシン | |
| CN102875533A (zh) | 达比加群衍生物、其制法及抗血栓用途 | |
| JP2023524996A5 (https=) | ||
| US20080275116A1 (en) | Carboxilic acid derivatives | |
| JP2023525527A5 (https=) |